Welcome IPQ Facebook fans!  We hope you enjoy this issue.  Seeing a complete issue will give you a better feel for the depth and breadth of our coverage and analysis.  We also hope you will consider a subscription or company license so you can have the full benefits of subscription, as do those at Pfizer, Lilly, Merck, Amgen, Roche, Boehringer, J&J, FDA and others.   Subscriptions and licenses help support IPQ so we can continue to bring you this valuable information and analysis.

Learn more about subscriptions/company licenses.

[download id=”32″]